The study reveals new evidence that reinforces the health consequences of exposure. Researchers identify troubling cause of certain kidney damage: 'We can't actually provide recommendations to help' ...

However, a recent recall affecting 6,804 bottles of metformin means some of the 20 million Americans on metformin will want ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Travere Therapeutics shares rose sharply in early trading Tuesday after the biopharmaceutical company said it plans to seek expanded Food and Drug Administration approval of its kidney-disease drug ...

Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for fo ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...